BXP Inc (BXP) and Healthpeak (DOC) on Torvanta's measures: BXP grades higher on 3 of the 4 factor families and DOC on 1.
| BXP | DOC | |
|---|---|---|
| Value grade | B- | C |
| Growth grade | C+ | C |
| Profitability grade | C | C- |
| Momentum grade | D+ | C- |
| Market value | $9.5B | $13.1B |
| P/E (trailing) | 31.8x | 54.2x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $3.5B | $2.9B |
| Revenue growth (y/y) | +2% | +6% |
| Operating margin | n/a | n/a |
| Return on invested capital | n/a | n/a |
| Free-cash-flow yield | 13.6% | 9.4% |
| Total return, 1 year | -12.0% | +9.8% |
| Total return, 3 years | +21.6% | +31.5% |
Full BXP analysis · Full DOC analysis
BXP Inc (BXP) and Healthpeak (DOC) on Torvanta's measures: BXP grades higher on 3 of the 4 factor families and DOC on 1. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings BXP trades at 31.8x and DOC at 54.2x; their value grades are B- and C against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer